News Focus
News Focus
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

Re: flatlander_60048 post# 10270

Saturday, 02/09/2013 9:27:10 AM

Saturday, February 09, 2013 9:27:10 AM

Post# of 20689
Copaxone's TRx market share remains more than 40%, according to Teva's 4Q12 CC.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”